Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Roy Buchanan is an analyst at JMP Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | CVAC | Buy Now | CureVac | $3.15 | 471.43% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/14/2024 | GRTS | Buy Now | Gritstone Bio | $0.60 | 727.68% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/07/2024 | ENTA | Buy Now | Enanta Pharma | $13.68 | 60.82% | $23 → $22 | Maintains | Market Outperform | Get Alert |
| 04/04/2024 | ABUS | Buy Now | Arbutus Biopharma | $3.23 | 23.84% | → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/02/2024 | GRTS | Buy Now | Gritstone Bio | $0.60 | 727.68% | $4 → $5 | Maintains | Market Outperform | Get Alert |
| 04/02/2024 | ANTX | Buy Now | AN2 Therapeutics | $2.62 | 129.01% | → $6 | Upgrade | Market Perform → Market Outperform | Get Alert |
| 02/28/2024 | GRTS | Buy Now | Gritstone Bio | $0.60 | 562.14% | → $4 | Initiates | → Market Outperform | Get Alert |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $2.62 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 01/04/2024 | INO | Buy Now | Inovio Pharmaceuticals | $8.46 | -88.18% | → $12 | Initiates | → Market Outperform | Get Alert |
| 01/04/2024 | ANTX | Buy Now | AN2 Therapeutics | $2.62 | 1045.04% | → $30 | Initiates | → Market Outperform | Get Alert |
| 11/21/2023 | ENTA | Buy Now | Enanta Pharma | $13.68 | 68.13% | $42 → $23 | Maintains | Outperform | Get Alert |
| 11/03/2023 | DVAX | Buy Now | Dynavax Technologies | $11.18 | 141.5% | $25 → $27 | Maintains | Market Outperform | Get Alert |
| 08/08/2023 | ENTA | Buy Now | Enanta Pharma | $13.68 | 207.02% | $65 → $42 | Maintains | Market Outperform | Get Alert |
| 08/04/2023 | DVAX | Buy Now | Dynavax Technologies | $11.18 | 123.61% | $24 → $25 | Maintains | Outperform | Get Alert |
| 07/18/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 07/06/2023 | ABUS | Buy Now | Arbutus Biopharma | $3.23 | 85.76% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/09/2023 | ENTA | Buy Now | Enanta Pharma | $13.68 | 375.15% | $82 → $65 | Maintains | Outperform | Get Alert |
| 05/03/2023 | DVAX | Buy Now | Dynavax Technologies | $11.18 | 114.67% | $25 → $24 | Maintains | Outperform | Get Alert |
| 04/26/2023 | CVAC | Buy Now | CureVac | $3.15 | 661.9% | $34 → $24 | Maintains | Outperform | Get Alert |
| 03/29/2023 | ABUS | Buy Now | Arbutus Biopharma | $3.23 | 85.76% | → $6 | Reiterates | → Market Outperform | Get Alert |
| 03/15/2023 | PRDS | Buy Now | Pardes Biosciences | — | — | $9 → $5 | Maintains | Market Outperform | Get Alert |
| 03/06/2023 | ESPR | Buy Now | Esperion Therapeutics | $2.42 | 519.83% | → $15 | Reiterates | → Market Outperform | Get Alert |
| 03/03/2023 | ARGX | Buy Now | argenx | $436.42 | 2.65% | $443 → $448 | Maintains | Market Outperform | Get Alert |
| 03/01/2023 | CRMD | Buy Now | Cormedix | $4.18 | 282.78% | $14 → $16 | Maintains | Market Perform | Get Alert |
| 02/24/2023 | DVAX | Buy Now | Dynavax Technologies | $11.18 | 123.61% | $22 → $25 | Maintains | Market Outperform | Get Alert |
| 02/16/2023 | IBIO | Buy Now | iBio | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 12/13/2022 | PRDS | Buy Now | Pardes Biosciences | — | — | → $9 | Initiates | → Market Outperform | Get Alert |
| 11/17/2022 | CVAC | Buy Now | CureVac | $3.15 | 979.37% | $37 → $34 | Maintains | Market Outperform | Get Alert |
| 09/27/2022 | DVAX | Buy Now | Dynavax Technologies | $11.18 | 96.78% | → $22 | Initiates | → Market Outperform | Get Alert |
| 08/09/2022 | ENTA | Buy Now | Enanta Pharma | $13.68 | 901.46% | $103 → $137 | Maintains | Market Outperform | Get Alert |
| 06/28/2022 | ABUS | Buy Now | Arbutus Biopharma | $3.23 | 178.64% | $10 → $9 | Maintains | Market Outperform | Get Alert |
| 05/19/2022 | ENTA | Buy Now | Enanta Pharma | $13.68 | 652.92% | $114 → $103 | Maintains | Market Outperform | Get Alert |
| 05/10/2022 | ENTA | Buy Now | Enanta Pharma | $13.68 | 733.33% | $116 → $114 | Maintains | Market Outperform | Get Alert |
| 04/22/2022 | CVAC | Buy Now | CureVac | $3.15 | 1074.6% | $52 → $37 | Maintains | Market Outperform | Get Alert |
| 01/18/2022 | CVAC | Buy Now | CureVac | $3.15 | 1550.79% | → $52 | Initiates | → Market Outperform | Get Alert |
| 12/21/2021 | ARGX | Buy Now | argenx | $436.42 | -4.22% | $368 → $418 | Maintains | Market Outperform | Get Alert |
| 11/29/2021 | IBIO | Buy Now | iBio | — | — | → $750 | Initiates | → Outperform | Get Alert |
